nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

09.02.2019 | Correspondence

Anaplastic Diffuse Large B Cell Lymphoma: A Single Center Experience

verfasst von: Neha Singh, Ridhi Sood, Narendra Agrawal, Sunil Pasricha, Anurag Mehta

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Gurbuxani S, Anastasi J, Hyjek E (2009) Diffuse large B-cell lymphoma–more than a diffuse collection of large B cells: an entity in search of a meaningful classification. Arch Pathol Lab Med 133:1121–1134PubMed

Gascoyne RD, Campo E, Jaffe ES, Chan WC et al (2017) Diffuse large B cell lymphoma, NOS. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of hematopoietic and lymphoid tissues, revised 4 edn. International Agency for Research on Cancer (IARC), Lyon, pp P292–P293

Diebold J, Anderson JR, Armitage JO, Connors JM, Maclennan KA, Müller-Hermelink HK et al (2002) Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification. Leuk Lymphoma 43(1):97–104CrossRefPubMed

Sakakibara A, Kohno K, Kuroda N, Yorita K, Megahed NA, Eladl AE et al (2018) Anaplastic variant of diffuse large B-cell lymphoma with hallmark cell appearance: two cases highlighting a broad diversity in the diagnostics. Pathol Int 68(4):251–255CrossRefPubMed

Romero-Guadarrama MB, Aguilar-Ayala LE, Ott G, Pérez-Espinosa J (2012) Diffuse large B-cell lymphoma with anaplastic clear cells: a rare variant. Open J Pathol 2:150–154CrossRef

Tilly H, Gaulard P, Lepage E et al (1997) Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 90:3727–3734PubMed

Lai R, Medeiros LJ, Dabbagh L, Formenti KS, Coupland RW (2000) Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma. Mod Pathol 13:223–228CrossRefPubMed

Li M, Liu Y, Wang Y et al (2017) Anaplastic variant of diffuse large Bcell lymphoma displays intricate genetic alterations and distinct biological features. Am J Surg Pathol 41:1322–1332CrossRefPubMed

Nakamura S, Shiota M, Nakagawa A et al (1997) Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. Am J Surg Pathol 21:1420–1432CrossRefPubMed

10.

Sarkozy C, Molina T, Ghesquieres H et al (2017) Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica 102:150–159CrossRefPubMedPubMedCentral

11.

Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer (IARC), Lyon

12.

Evens AM, Kanakry JA, Sehn LH et al (2015) Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. Am J Hematol 90:778–783CrossRefPubMed

13.

Mittal M, Puri A, Nangia R, Sachdeva A (2015) Follicular lymphoma transforming into anaplastic diffuse large B-cell lymphoma of oral cavity: a case report with review of literature. J Oral Maxillofac Pathol 19(3):379–384CrossRefPubMedPubMedCentral

14.

Hu S, Xu-Monette ZY, Balasubramanyam A, Manyam GC, Visco C, Tzankov A et al (2013) CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood 121(14):2715–2724CrossRefPubMedPubMedCentral

15.

Slack GW, Steidl C, Sehn LH, Gascoyne RD (2014) CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia. Br J Haematol 167(5):608–617CrossRefPubMed

16.

Hao X, Wei X, Huang F, Wei Y, Zeng H, Xu L et al (2015) The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma. PLoS ONE 10(5):e0126615CrossRefPubMedPubMedCentral

17.

Collie AMB, Hill BT, Manilich EA, Smith MR, His ED (2013) CD30 immunohistochemical expression in diffuse large B-cell lymphoma is associated with decreased overall survival and the non-germinal center molecular subtype. Blood 122:4318

Titel: Anaplastic Diffuse Large B Cell Lymphoma: A Single Center Experience
verfasst von: Neha Singh
Ridhi Sood
Narendra Agrawal
Sunil Pasricha
Anurag Mehta
Publikationsdatum: 09.02.2019
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2019
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-019-01096-8

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Anaplastic Diffuse Large B Cell Lymphoma: A Single Center Experience

Excerpt

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience

Caregiver Burden in the Patients of Acute Myeloblastic Leukemia

Obituary: Professor Sir David John Weatherall GBE, MD, FRCP, FRS

Establishing Blood Group Genotyping to Resolve ABO Discrepancies in Iran

Spectrum of Hemoglobinopathies: A New Revelation in a Tertiary Care Hospital of Odisha

Recurrent Arterial and Venous Thrombosis in Chronic Immune Thrombocytopenia: Clinical Paradox and Therapeutic Challenges

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie